HeartFlow, Inc. (HTFL) Price & Analysis

Compare

27 Followers

HTFL Stock Chart & Stats

$29.62

Market closed

$29.62

Day’s Range― - ―

52-Week Range$25.75 - $41.22

Previous CloseN/A

VolumeN/A

Average Volume (3M)482.80K

Market Cap

N/A

Enterprise Value$2.54B

Total Cash (Recent Filing)$291.17M

Total Debt (Recent Filing)$21.79M

Price to Earnings (P/E)―

Beta2.42

Next Earnings

Feb 12, 2026

EPS Estimate

-0.17

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.27

Shares Outstanding85,158,720

10 Day Avg. Volume580,443

30 Day Avg. Volume482,804

Financial Highlights & Ratios

PEG Ratio0.81

Price to Book (P/B)-2.11

Price to Sales (P/S)14.41

P/FCF Ratio-24.71

Enterprise Value/Market Cap10.00T>

Enterprise Value/Revenue20.02

Enterprise Value/Gross Profit26.43

Enterprise Value/Ebitda-53.61

Forecast

1Y Price Target

$38.60

Price Target Upside30.32% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

EPS Forecast (FY)-1.95

Revenue Forecast (FY)$165.86M

Bulls Say, Bears Say

Bulls Say

Market ExpansionHeartflow is poised to deliver above-average growth and margin performance, with a projected 24% growth CAGR in the 2025-2028 period and potential gross margin expansion to 83%.

Reimbursement And CoverageCMS kept HTFL’s plaque reimbursement assigned to New Tech APC 1511, which under OPPS will reimburse $950.50 starting January 1, 2026, as expected.

Revenue GrowthHeartFlow delivered a strong performance in its first public quarter, beating both internal and consensus revenue estimates.

Bears Say

Adoption BarriersHeartflow’s long-term sales growth will largely rely on expanding its hospital footprint and increasing utilization of CCTA across the U.S., and any changes to reimbursement codes could disincentivize adoption of Heartflow’s software solutions.

Pricing PressureA slightly lower implied US ASP than expected, but it is offset by a higher installed base and revenue cases per site.

Reimbursement ChallengesMovement in some components of the APC are dragging down the reimbursement rate for FFRct, with the payment rate in 2026 finalized at $877.34 compared to previous $1,017.

HeartFlow, Inc. News

Heartflow price target raised to $40 from $35 at Stifel

Stifel raised the firm’s price target on Heartflow (HTFL) to $40 from $35 and keeps a Buy rating...

21d ago

HTFL

Heartflow price target raised to $40 from $36 at JPMorgan

JPMorgan analyst Robbie Marcus raised the firm’s price target on Heartflow (HTFL) to $40 from $36 and keeps...

21d ago

HTFL

Heartflow price target raised to $40 from $39 at Canaccord

Canaccord raised the firm’s price target on Heartflow (HTFL) to $40 from $39 and keeps a Buy rating...

21d ago

HTFL

Heartflow reports Q3 EPS (27c), consensus (24c)

Reports Q3 revenue $46.28M, consensus $41.96M. “Heartflow (HTFL) delivered an outstanding third quarter of 2025,” said John Farquhar,...

22d ago

HTFL

Heartflow sees FY25 revenue view $173M-$173.5M, consensus $165.97M

The company said, “Heartflow (HTFL) expects total revenue for the full year 2025 to be in the range...

22d ago

HTFL

Heartflow announces data from FISH&CHIPS Study on Heartflow Plaque Analysis

Heartflow (HTFL) announced late-breaking data from the FISH&CHIPS Study presented at the American Heart Association, AHA, Scientific Sessions...

25d ago

HTFL

HeartFlow, Inc. Receives Buy Rating from William Plovanic Due to Strong Market Performance and Growth Potential

William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on HeartFlow, Inc.. The associated price target...

21d ago

HTFL

HeartFlow, Inc.: Promising Growth with Valuation Concerns Justifying Hold Rating

Morgan Stanley analyst Patrick Wood has maintained their neutral stance on HTFL stock, giving a Hold rating yesterday....

21d ago

HTFL

HeartFlow, Inc. Reports Robust Q3 2025 Revenue Growth

HeartFlow, Inc. ( ($HTFL) ) has released its Q3 earnings. Here is a breakdown of the information HeartFlow,...

22d ago

HTFL

HeartFlow’s Innovative Study on Cardiac Risk in NFL Alumni: A Potential Game-Changer

HeartFlow, Inc. (($HTFL)) announced an update on their ongoing clinical study. HeartFlow, Inc. is conducting a clinical study...

1M ago

HTFL

HeartFlow’s COMPLETE Study: A New Frontier in Coronary Artery Disease Evaluation

HeartFlow, Inc. (($HTFL)) announced an update on their ongoing clinical study. The COMPLETE Study, officially titled ‘Comprehensive Anatomical...

1M ago

HTFL

Heartflow introduces Heartflow PCI Navigator

Heartflow (HTFL) introduced Heartflow PCI Navigator, the newest addition to the Heartflow One platform. PCI Navigator is the...

1M ago

HTFL

Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage

Heartflow (HTFL) announced it has received FDA 510 clearance for its Next Gen Heartflow Plaque Analysis algorithm and...

2M ago

HTFL

Heartflow price target raised to $39 from $35 at Canaccord

Canaccord raised the firm’s price target on Heartflow (HTFL) to $39 from $35 and keeps a Buy rating...

2M ago

HTFL

HTFL FAQ

What was HeartFlow, Inc.’s price range in the past 12 months?

HeartFlow, Inc. lowest stock price was $25.75 and its highest was $41.22 in the past 12 months.

What is HeartFlow, Inc.’s market cap?

Currently, no data Available

When is HeartFlow, Inc.’s upcoming earnings report date?

HeartFlow, Inc.’s upcoming earnings report date is Feb 12, 2026 which is in 70 days.

How were HeartFlow, Inc.’s earnings last quarter?

HeartFlow, Inc. released its earnings results on Nov 12, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.242 by -$0.028.

Is HeartFlow, Inc. overvalued?

According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does HeartFlow, Inc. pay dividends?

HeartFlow, Inc. does not currently pay dividends.

What is HeartFlow, Inc.’s EPS estimate?

HeartFlow, Inc.’s EPS estimate is -0.17.

How many shares outstanding does HeartFlow, Inc. have?

HeartFlow, Inc. has 85,158,720 shares outstanding.

What happened to HeartFlow, Inc.’s price movement after its last earnings report?

HeartFlow, Inc. reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.242. Following the earnings report the stock price went down -13.43%.

Which hedge fund is a major shareholder of HeartFlow, Inc.?

Currently, no hedge funds are holding shares in HTFL

Company Description

HeartFlow, Inc.

HeartFlow, Inc. is a medical technology company focused on transforming cardiovascular care through its innovative imaging solutions. It operates primarily within the healthcare sector, specializing in non-invasive coronary artery disease diagnostics. HeartFlow's core product, the HeartFlow Analysis, utilizes advanced computational fluid dynamics to create a personalized 3D model of a patient's coronary arteries, allowing physicians to assess the impact of blockages and make informed treatment decisions.

HeartFlow, Inc. (HTFL) Earnings & Revenues

Historic Earnings Reports

HTFL Earnings Call

Q3 2025

0:00 / 0:00

HTFL Stock 12 Month Forecast

Average Price Target

$38.60

▲(30.32% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","41":"$41","31.25":"$31.3","34.5":"$34.5","37.75":"$37.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$38.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$35.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,31.25,34.5,37.75,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.16,37.378461538461536,37.596923076923076,37.815384615384616,38.03384615384615,38.25230769230769,38.47076923076923,38.68923076923077,38.90769230769231,39.12615384615385,39.34461538461538,39.56307692307692,39.78153846153846,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.16,37.270769230769226,37.38153846153846,37.49230769230769,37.60307692307692,37.713846153846156,37.824615384615385,37.93538461538461,38.04615384615384,38.15692307692308,38.26769230769231,38.378461538461536,38.48923076923077,{"y":38.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.16,36.99384615384615,36.8276923076923,36.661538461538456,36.495384615384616,36.32923076923077,36.16307692307692,35.996923076923075,35.83076923076923,35.66461538461538,35.49846153846154,35.332307692307694,35.16615384615385,{"y":35,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.99,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.99,"date":1754006400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.16,"date":1756684800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.16,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.16,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >